返回 Agenda
Session 9: Building AI and Machine Learning Innovations for Credible Real-World Evidence Generation
Session Chair(s)
Lina Titievsky, PhD, MPH
Head of Hepatology Epidemiology, GlaxoSmithKline, United States
Matthew Curtis
Director of Regulatory Affairs, AstraZeneca, United States
Session 9: Building AI and Machine Learning Innovations for Credible Real-World Evidence Generation
Speaker(s)
John Diaz-Decaro, PhD, MS
Founder, Black Swan Causal Labs, United States
Operationalizing AI Governance for RWE: A Comparative Analysis of Regulatory, HTA, and Specialty Bodies
Representative Invited
Director, Johnson and Johnson Innovative Medicine, United States
Establish Credibility for AI Enabled Real World Evidence in Regulatory Decision Making: From Promise to Practice
Representative Invited
Director, Business Strategy, IQVIA, United States
Minutes, Not Days: Off-the-Shelf Generative AI in RWE — Works, What Doesn't, and Why Humans Stay in the Loop